dr. A. (Albert) Batalla Cases

Assistant Professor - medical

  • Psychiatry

dr. A. (Albert) Batalla Cases


Albert Batalla completed the Bachelor of Medicine and Surgery (BMBS) in 2017 (Autonomous University of Barcelona), being granted with the Extraordinary Award of Bachelor. In 2008 he started the residency in Psychiatry at Hospital Clínic de Barcelona, where he became interested in the neurobiology of cannabis use and its relation to psychotic disorders. In 2011 he started his PhD at the Department of Psychiatry and Clinical Psychobiology, University of Barcelona, under the supervision of Dr. Martín-Santos. In 2012 he performed a four-month traineeship at the neuroimaging lab of Melbourne Neuropsychiatry Centre, University of Melbourne, under the supervision of Prof. Murat Yücel. That same year he completed the residency of Psychiatry and started working as pre-doctoral researcher at the Fundació Clínic per a la Recerca Biomèdica (FCRB). He studied the impact of addiction (cannabis) on the outcome of psychotic disorders, cognitive control and brain volume, revealing gene-environment interactions that play a role in the sensitivity to the effects of cannabis on the brain. He completed his PhD in July 2014.

That same year he moved to the Netherlands, where he started working as a psychiatrist in Tactus Addiction Treatment and temporarily as postdoc at FCRB. In 2015 he joined NISPA ( and he got a position as senior lecturer (Master in Addiction Medicine) at the Radboud University and as a psychiatrist at the Radboud University Medical Center. Since 2018 he works as a psychiatrist and researcher at the University Medical Center Utrecht. His research focusses on the relation between early psychosis and substance use disorders, particularly cannabis use. He is involved in international projects (e.g. ENIGMA consortium), has published several articles and is a reviewer of international journals.

Research Output (49)

Cortical changes in adolescents with psychosis risk syndrome: Progressive cortical thinning and transition to psychosis

Fortea A., Van Eijndhoven P., Pariente J., Batalla A., Masias M., De la Serna E., Tor J., Dolz M., Baeza I., Sugranyes G. dec 2019, In: European Neuropsychopharmacology. 29 , p. S525-S526

The Potential of Cannabidiol as a Treatment for Psychosis and Addiction:Who Benefits Most? A Systematic Review

Batalla Albert, Janssen Hella, Gangadin Shiral S, Bossong Matthijs G 19 jul 2019, In: Journal of Clinical medicine. 8

Delayed complications after severe clozapine intoxication:a case report. The pharmacokinetic profile of clozapine and it's important role in the course of symptoms

van Helvoort Marloes, van Eijndhoven Philip, Schellekens Arnt, Pop-Purceleanu Monica, Kramers Cornelis, Batalla Albert 17 mei 2019, In: International Clinical Psychopharmacology. 34 , p. 269-272 4 p.

Comorbid psychosis and addiction: practical and novel approaches

Batalla A. apr 2019, In: European Psychiatry. 56 , p. S656-S656

Cerebellar alterations in cannabis users:A systematic review

Blithikioti Chrysanthi, Miquel Laia, Batalla Albert, Rubio Belen, Maffei Giovanni, Herreros Ivan, Gual Antoni, Verschure Paul, Balcells-Oliveró Mercedes 27 feb 2019, In: Addiction Biology. 24 , p. 1121-1137 17 p.

The neuroanatomy of cannabis use: does gender matter? Findings from the ENIGMA addiction working group

Rossetti M. G., Mackey S., Patalay P., Batalla A., Bellani M., Chye Y. Y., Conrod P., Cousijn J., Garavan H., Solowij N., Suo C., Thompson P. M., Yucel M., Brambilla P., Lorenzetti V. 2019, In: European Neuropsychopharmacology. 29 , p. S182-S183

Reward processing in Attention-Deficit/Hyperactivity Disorder and healthy controls at high risk for Substance Use Disorders

Paraskevopoulou M., Van Rooij D., Batalla A., Schene A. H., Buitelaar J. K., Schellekens A. F. A. 2019, In: European Neuropsychopharmacology. 29 , p. S485-S486

Cortical thickness in the anterior cingulate correlates with apoptotic markers in cultured fibroblasts in first-episode schizophrenia individuals

Fortea A., Pariente J. C., Batalla A., Bargallo N., Gasso P., Mas S., Lafuente A., Parellada E. 2019, In: European Neuropsychopharmacology. 29 , p. S601-S602

Cortical surface area abnormalities in young adolescents at ultra-high risk who later develop psychosis

Madero Gomez S., Fortea A., Van Eindhjoven P., Pariente J. C., Calvo A., Batalla A., De la Serna E., Ilzarbe D., Dolz M., Baeza I., Sugranyes G. 2019, In: European Neuropsychopharmacology. 29 , p. S305-S306

Effects of excessive substance use on inhibitory control in patients with attention-deficit/hyperactivity disorder

Paraskevopoulou M., Van Rooij D., Batalla A., Schene A. H., Buitelaar J. K., Schellekens A. F. A. 2019, In: European Neuropsychopharmacology. 29 , p. S673-S674

All Research Output (49)